Global Viral Vector Development Service Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Development Service Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Adeno-associated Viral Vectors
1.2.6 Others Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vector Development Service Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Manufacturers
1.3.3 Biotechnology Companies
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Development Service Market Perspective (2016-2027)
2.2 Viral Vector Development Service Growth Trends by Regions
2.2.1 Viral Vector Development Service Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Viral Vector Development Service Historic Market Share by Regions (2016-2021)
2.2.3 Viral Vector Development Service Forecasted Market Size by Regions (2022-2027)
2.3 Viral Vector Development Service Industry Dynamic
2.3.1 Viral Vector Development Service Market Trends
2.3.2 Viral Vector Development Service Market Drivers
2.3.3 Viral Vector Development Service Market Challenges
2.3.4 Viral Vector Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Development Service Players by Revenue
3.1.1 Global Top Viral Vector Development Service Players by Revenue (2016-2021)
3.1.2 Global Viral Vector Development Service Revenue Market Share by Players (2016-2021)
3.2 Global Viral Vector Development Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Viral Vector Development Service Revenue
3.4 Global Viral Vector Development Service Market Concentration Ratio
3.4.1 Global Viral Vector Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Development Service Revenue in 2020
3.5 Viral Vector Development Service Key Players Head office and Area Served
3.6 Key Players Viral Vector Development Service Product Solution and Service
3.7 Date of Enter into Viral Vector Development Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Development Service Breakdown Data by Type
4.1 Global Viral Vector Development Service Historic Market Size by Type (2016-2021)
4.2 Global Viral Vector Development Service Forecasted Market Size by Type (2022-2027)
5 Viral Vector Development Service Breakdown Data by Application
5.1 Global Viral Vector Development Service Historic Market Size by Application (2016-2021)
5.2 Global Viral Vector Development Service Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Viral Vector Development Service Market Size (2016-2027)
6.2 North America Viral Vector Development Service Market Size by Type
6.2.1 North America Viral Vector Development Service Market Size by Type (2016-2021)
6.2.2 North America Viral Vector Development Service Market Size by Type (2022-2027)
6.2.3 North America Viral Vector Development Service Market Size by Type (2016-2027)
6.3 North America Viral Vector Development Service Market Size by Application
6.3.1 North America Viral Vector Development Service Market Size by Application (2016-2021)
6.3.2 North America Viral Vector Development Service Market Size by Application (2022-2027)
6.3.3 North America Viral Vector Development Service Market Size by Application (2016-2027)
6.4 North America Viral Vector Development Service Market Size by Country
6.4.1 North America Viral Vector Development Service Market Size by Country (2016-2021)
6.4.2 North America Viral Vector Development Service Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Viral Vector Development Service Market Size (2016-2027)
7.2 Europe Viral Vector Development Service Market Size by Type
7.2.1 Europe Viral Vector Development Service Market Size by Type (2016-2021)
7.2.2 Europe Viral Vector Development Service Market Size by Type (2022-2027)
7.2.3 Europe Viral Vector Development Service Market Size by Type (2016-2027)
7.3 Europe Viral Vector Development Service Market Size by Application
7.3.1 Europe Viral Vector Development Service Market Size by Application (2016-2021)
7.3.2 Europe Viral Vector Development Service Market Size by Application (2022-2027)
7.3.3 Europe Viral Vector Development Service Market Size by Application (2016-2027)
7.4 Europe Viral Vector Development Service Market Size by Country
7.4.1 Europe Viral Vector Development Service Market Size by Country (2016-2021)
7.4.2 Europe Viral Vector Development Service Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Development Service Market Size (2016-2027)
8.2 Asia-Pacific Viral Vector Development Service Market Size by Type
8.2.1 Asia-Pacific Viral Vector Development Service Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Viral Vector Development Service Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Viral Vector Development Service Market Size by Type (2016-2027)
8.3 Asia-Pacific Viral Vector Development Service Market Size by Application
8.3.1 Asia-Pacific Viral Vector Development Service Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Viral Vector Development Service Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Viral Vector Development Service Market Size by Application (2016-2027)
8.4 Asia-Pacific Viral Vector Development Service Market Size by Region
8.4.1 Asia-Pacific Viral Vector Development Service Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Viral Vector Development Service Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Viral Vector Development Service Market Size (2016-2027)
9.2 Latin America Viral Vector Development Service Market Size by Type
9.2.1 Latin America Viral Vector Development Service Market Size by Type (2016-2021)
9.2.2 Latin America Viral Vector Development Service Market Size by Type (2022-2027)
9.2.3 Latin America Viral Vector Development Service Market Size by Type (2016-2027)
9.3 Latin America Viral Vector Development Service Market Size by Application
9.3.1 Latin America Viral Vector Development Service Market Size by Application (2016-2021)
9.3.2 Latin America Viral Vector Development Service Market Size by Application (2022-2027)
9.3.3 Latin America Viral Vector Development Service Market Size by Application (2016-2027)
9.4 Latin America Viral Vector Development Service Market Size by Country
9.4.1 Latin America Viral Vector Development Service Market Size by Country (2016-2021)
9.4.2 Latin America Viral Vector Development Service Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Development Service Market Size (2016-2027)
10.2 Middle East & Africa Viral Vector Development Service Market Size by Type
10.2.1 Middle East & Africa Viral Vector Development Service Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Viral Vector Development Service Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Viral Vector Development Service Market Size by Type (2016-2027)
10.3 Middle East & Africa Viral Vector Development Service Market Size by Application
10.3.1 Middle East & Africa Viral Vector Development Service Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Viral Vector Development Service Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Viral Vector Development Service Market Size by Application (2016-2027)
10.4 Middle East & Africa Viral Vector Development Service Market Size by Country
10.4.1 Middle East & Africa Viral Vector Development Service Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Viral Vector Development Service Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 UJIFILM Diosynth Biotechnologies
11.1.1 UJIFILM Diosynth Biotechnologies Company Details
11.1.2 UJIFILM Diosynth Biotechnologies Business Overview
11.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Introduction
11.1.4 UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2016-2021)
11.1.5 UJIFILM Diosynth Biotechnologies Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Viral Vector Development Service Introduction
11.2.4 Sanofi Revenue in Viral Vector Development Service Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Viral Vector Development Service Introduction
11.3.4 Spark Therapeutics Revenue in Viral Vector Development Service Business (2016-2021)
11.3.5 Spark Therapeutics Recent Development
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector Development Service Introduction
11.4.4 UniQure Revenue in Viral Vector Development Service Business (2016-2021)
11.4.5 UniQure Recent Development
11.5 MassBiologics
11.5.1 MassBiologics Company Details
11.5.2 MassBiologics Business Overview
11.5.3 MassBiologics Viral Vector Development Service Introduction
11.5.4 MassBiologics Revenue in Viral Vector Development Service Business (2016-2021)
11.5.5 MassBiologics Recent Development
11.6 FinVector
11.6.1 FinVector Company Details
11.6.2 FinVector Business Overview
11.6.3 FinVector Viral Vector Development Service Introduction
11.6.4 FinVector Revenue in Viral Vector Development Service Business (2016-2021)
11.6.5 FinVector Recent Development
11.7 Thermo Fisher Scientific (Brammer Bio)
11.7.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.7.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Introduction
11.7.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Development Service Business (2016-2021)
11.7.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.8 Cell and Gene Therapy Catapult
11.8.1 Cell and Gene Therapy Catapult Company Details
11.8.2 Cell and Gene Therapy Catapult Business Overview
11.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Introduction
11.8.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2016-2021)
11.8.5 Cell and Gene Therapy Catapult Recent Development
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Details
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Viral Vector Development Service Introduction
11.9.4 Cobra Biologics Revenue in Viral Vector Development Service Business (2016-2021)
11.9.5 Cobra Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Viral Vector Development Service Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Retroviral Vectors
Table 3. Key Players of Lentiviral Vectors
Table 4. Key Players of Adenoviral Vectors
Table 5. Key Players of Adeno-associated Viral Vectors
Table 6. Key Players of Others Viral Vectors
Table 7. Global Viral Vector Development Service Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Viral Vector Development Service Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Viral Vector Development Service Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Viral Vector Development Service Market Share by Regions (2016-2021)
Table 11. Global Viral Vector Development Service Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Viral Vector Development Service Market Share by Regions (2022-2027)
Table 13. Viral Vector Development Service Market Trends
Table 14. Viral Vector Development Service Market Drivers
Table 15. Viral Vector Development Service Market Challenges
Table 16. Viral Vector Development Service Market Restraints
Table 17. Global Viral Vector Development Service Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Viral Vector Development Service Market Share by Players (2016-2021)
Table 19. Global Top Viral Vector Development Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Development Service as of 2020)
Table 20. Ranking of Global Top Viral Vector Development Service Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Viral Vector Development Service Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Viral Vector Development Service Product Solution and Service
Table 24. Date of Enter into Viral Vector Development Service Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Vector Development Service Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Viral Vector Development Service Revenue Market Share by Type (2016-2021)
Table 28. Global Viral Vector Development Service Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Viral Vector Development Service Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Viral Vector Development Service Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Viral Vector Development Service Revenue Market Share by Application (2016-2021)
Table 32. Global Viral Vector Development Service Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Viral Vector Development Service Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Viral Vector Development Service Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Viral Vector Development Service Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Viral Vector Development Service Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Viral Vector Development Service Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Viral Vector Development Service Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Viral Vector Development Service Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Viral Vector Development Service Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Viral Vector Development Service Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Viral Vector Development Service Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Viral Vector Development Service Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Viral Vector Development Service Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Viral Vector Development Service Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Viral Vector Development Service Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Viral Vector Development Service Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Viral Vector Development Service Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Viral Vector Development Service Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Viral Vector Development Service Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Viral Vector Development Service Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Viral Vector Development Service Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Viral Vector Development Service Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Viral Vector Development Service Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Viral Vector Development Service Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Viral Vector Development Service Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Viral Vector Development Service Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Viral Vector Development Service Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Viral Vector Development Service Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Viral Vector Development Service Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Viral Vector Development Service Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Viral Vector Development Service Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Viral Vector Development Service Market Size by Country (2022-2027) & (US$ Million)
Table 64. UJIFILM Diosynth Biotechnologies Company Details
Table 65. UJIFILM Diosynth Biotechnologies Business Overview
Table 66. UJIFILM Diosynth Biotechnologies Viral Vector Development Service Product
Table 67. UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 68. UJIFILM Diosynth Biotechnologies Recent Development
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Viral Vector Development Service Product
Table 72. Sanofi Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 73. Sanofi Recent Development
Table 74. Spark Therapeutics Company Details
Table 75. Spark Therapeutics Business Overview
Table 76. Spark Therapeutics Viral Vector Development Service Product
Table 77. Spark Therapeutics Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 78. Spark Therapeutics Recent Development
Table 79. UniQure Company Details
Table 80. UniQure Business Overview
Table 81. UniQure Viral Vector Development Service Product
Table 82. UniQure Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 83. UniQure Recent Development
Table 84. MassBiologics Company Details
Table 85. MassBiologics Business Overview
Table 86. MassBiologics Viral Vector Development Service Product
Table 87. MassBiologics Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 88. MassBiologics Recent Development
Table 89. FinVector Company Details
Table 90. FinVector Business Overview
Table 91. FinVector Viral Vector Development Service Product
Table 92. FinVector Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 93. FinVector Recent Development
Table 94. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 95. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 96. Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Product
Table 97. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 98. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 99. Cell and Gene Therapy Catapult Company Details
Table 100. Cell and Gene Therapy Catapult Business Overview
Table 101. Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 102. Cell and Gene Therapy Catapult Recent Development
Table 103. Cobra Biologics Company Details
Table 104. Cobra Biologics Business Overview
Table 105. Cobra Biologics Viral Vector Development Service Product
Table 106. Cobra Biologics Revenue in Viral Vector Development Service Business (2016-2021) & (US$ Million)
Table 107. Cobra Biologics Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Viral Vector Development Service Market Share by Type: 2020 VS 2027
Figure 2. Retroviral Vectors Features
Figure 3. Lentiviral Vectors Features
Figure 4. Adenoviral Vectors Features
Figure 5. Adeno-associated Viral Vectors Features
Figure 6. Others Viral Vectors Features
Figure 7. Global Viral Vector Development Service Market Share by Application: 2020 VS 2027
Figure 8. Pharmaceutical Manufacturers Case Studies
Figure 9. Biotechnology Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Viral Vector Development Service Report Years Considered
Figure 12. Global Viral Vector Development Service Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Viral Vector Development Service Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Viral Vector Development Service Market Share by Regions: 2020 VS 2027
Figure 15. Global Viral Vector Development Service Market Share by Regions (2022-2027)
Figure 16. Global Viral Vector Development Service Market Share by Players in 2020
Figure 17. Global Top Viral Vector Development Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Development Service as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Viral Vector Development Service Revenue in 2020
Figure 19. Global Viral Vector Development Service Revenue Market Share by Type (2016-2021)
Figure 20. Global Viral Vector Development Service Revenue Market Share by Type (2022-2027)
Figure 21. North America Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Viral Vector Development Service Market Share by Type (2016-2027)
Figure 23. North America Viral Vector Development Service Market Share by Application (2016-2027)
Figure 24. North America Viral Vector Development Service Market Share by Country (2016-2027)
Figure 25. United States Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Viral Vector Development Service Market Share by Type (2016-2027)
Figure 29. Europe Viral Vector Development Service Market Share by Application (2016-2027)
Figure 30. Europe Viral Vector Development Service Market Share by Country (2016-2027)
Figure 31. Germany Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Viral Vector Development Service Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Viral Vector Development Service Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Viral Vector Development Service Market Share by Region (2016-2027)
Figure 41. China Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Viral Vector Development Service Market Share by Type (2016-2027)
Figure 49. Latin America Viral Vector Development Service Market Share by Application (2016-2027)
Figure 50. Latin America Viral Vector Development Service Market Share by Country (2016-2027)
Figure 51. Mexico Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Viral Vector Development Service Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Viral Vector Development Service Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Viral Vector Development Service Market Share by Country (2016-2027)
Figure 57. Turkey Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Viral Vector Development Service Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 62. Spark Therapeutics Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 63. UniQure Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 64. MassBiologics Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 65. FinVector Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 66. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 67. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 68. Cobra Biologics Revenue Growth Rate in Viral Vector Development Service Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed